Raymond J. Henley Iii

Array ( [id] => 1412355 [patent_doc_number] => 06528540 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-03-04 [patent_title] => 'Esmolol formulation' [patent_app_type] => B2 [patent_app_number] => 10/016260 [patent_app_country] => US [patent_app_date] => 2001-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2437 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/528/06528540.pdf [firstpage_image] =>[orig_patent_app_number] => 10016260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1521183 [patent_doc_number] => 06413988 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-02 [patent_title] => 'Prucalopride oral solution' [patent_app_type] => B1 [patent_app_number] => 09/980848 [patent_app_country] => US [patent_app_date] => 2001-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2123 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/413/06413988.pdf [firstpage_image] =>[orig_patent_app_number] => 09980848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1460211 [patent_doc_number] => 06391920 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => 'Methods of treating androgen deficiency in men using selective antiestrogens' [patent_app_type] => B1 [patent_app_number] => 09/980652 [patent_app_country] => US [patent_app_date] => 2001-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1218 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/391/06391920.pdf [firstpage_image] =>[orig_patent_app_number] => 09980652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7460553 [patent_doc_number] => 20040052829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Vertebral augmentation composition and method' [patent_app_type] => new [patent_app_number] => 10/399423 [patent_app_country] => US [patent_app_date] => 2003-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4593 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20040052829.pdf [firstpage_image] =>[orig_patent_app_number] => 10399423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7395666 [patent_doc_number] => 20040022778 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction' [patent_app_type] => new [patent_app_number] => 10/399639 [patent_app_country] => US [patent_app_date] => 2003-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6407 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20040022778.pdf [firstpage_image] =>[orig_patent_app_number] => 10399639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1517611 [patent_doc_number] => 06500835 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-12-31 [patent_title] => 'Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as the active ingredient' [patent_app_type] => B2 [patent_app_number] => 09/959232 [patent_app_country] => US [patent_app_date] => 2001-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 14378 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/500/06500835.pdf [firstpage_image] =>[orig_patent_app_number] => 09959232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1388606 [patent_doc_number] => 06548508 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-04-15 [patent_title] => 'Use of PDE V inhibitors for improved fecundity in mammals' [patent_app_type] => B2 [patent_app_number] => 09/982445 [patent_app_country] => US [patent_app_date] => 2001-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 12 [patent_no_of_words] => 6929 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/548/06548508.pdf [firstpage_image] =>[orig_patent_app_number] => 09982445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5969132 [patent_doc_number] => 20020091144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-11 [patent_title] => 'Treatment of apoptotic cell death' [patent_app_type] => new [patent_app_number] => 09/977558 [patent_app_country] => US [patent_app_date] => 2001-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5352 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20020091144.pdf [firstpage_image] =>[orig_patent_app_number] => 09977558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1553955 [patent_doc_number] => 06348486 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-19 [patent_title] => 'Methods for modulating bladder function' [patent_app_type] => B1 [patent_app_number] => 09/977828 [patent_app_country] => US [patent_app_date] => 2001-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4166 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/348/06348486.pdf [firstpage_image] =>[orig_patent_app_number] => 09977828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6726901 [patent_doc_number] => 20030183091 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Compositions for improving lipid metabolism' [patent_app_type] => new [patent_app_number] => 10/399145 [patent_app_country] => US [patent_app_date] => 2003-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5010 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20030183091.pdf [firstpage_image] =>[orig_patent_app_number] => 10399145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7645588 [patent_doc_number] => 06472381 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-29 [patent_title] => 'Method of treating psoriasis' [patent_app_type] => B1 [patent_app_number] => 09/975792 [patent_app_country] => US [patent_app_date] => 2001-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2534 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/472/06472381.pdf [firstpage_image] =>[orig_patent_app_number] => 09975792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1313160 [patent_doc_number] => 06610693 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-08-26 [patent_title] => 'Fructosamine oxidase: antagonists and inhibitors' [patent_app_type] => B2 [patent_app_number] => 09/975751 [patent_app_country] => US [patent_app_date] => 2001-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9372 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/610/06610693.pdf [firstpage_image] =>[orig_patent_app_number] => 09975751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1560248 [patent_doc_number] => 06436938 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Combination treatment for depression' [patent_app_type] => B1 [patent_app_number] => 09/973614 [patent_app_country] => US [patent_app_date] => 2001-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8642 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/436/06436938.pdf [firstpage_image] =>[orig_patent_app_number] => 09973614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1388592 [patent_doc_number] => 06548507 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-15 [patent_title] => 'Medical use' [patent_app_type] => B1 [patent_app_number] => 09/958429 [patent_app_country] => US [patent_app_date] => 2001-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3048 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/548/06548507.pdf [firstpage_image] =>[orig_patent_app_number] => 09958429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1470308 [patent_doc_number] => 06407113 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-18 [patent_title] => 'Medicament for treatment of diastolic dysfunction' [patent_app_type] => B1 [patent_app_number] => 09/969649 [patent_app_country] => US [patent_app_date] => 2001-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4377 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/407/06407113.pdf [firstpage_image] =>[orig_patent_app_number] => 09969649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1507858 [patent_doc_number] => 06440963 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Use of selective COX-2 inhibitors for the treatment of urinary incontinence' [patent_app_type] => B1 [patent_app_number] => 09/969538 [patent_app_country] => US [patent_app_date] => 2001-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11596 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/440/06440963.pdf [firstpage_image] =>[orig_patent_app_number] => 09969538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6131670 [patent_doc_number] => 20020077358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'Use of hydroperoxyeicosatetraenoic acid derivatives following refractive surgery' [patent_app_type] => new [patent_app_number] => 09/965506 [patent_app_country] => US [patent_app_date] => 2001-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1802 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20020077358.pdf [firstpage_image] =>[orig_patent_app_number] => 09965506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1545982 [patent_doc_number] => 06444695 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-03 [patent_title] => 'Inhibition of thrombin-induced platelet aggregation by creatine kinase inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/960822 [patent_app_country] => US [patent_app_date] => 2001-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10546 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/444/06444695.pdf [firstpage_image] =>[orig_patent_app_number] => 09960822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5923487 [patent_doc_number] => 20020115716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Oral low dose butyrate compositions' [patent_app_type] => new [patent_app_number] => 09/955707 [patent_app_country] => US [patent_app_date] => 2001-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2074 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115716.pdf [firstpage_image] =>[orig_patent_app_number] => 09955707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1412175 [patent_doc_number] => 06528530 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-03-04 [patent_title] => 'Phenidate drug formulations having diminished abuse potential' [patent_app_type] => B2 [patent_app_number] => 09/955556 [patent_app_country] => US [patent_app_date] => 2001-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4820 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/528/06528530.pdf [firstpage_image] =>[orig_patent_app_number] => 09955556 [rel_patent_id] =>[rel_patent_doc_number] =>)